Sklamberg Quoted in Bloomberg Law on Government Shutdown Implications for FDA
September 30, 2021
Life Sciences & Healthcare Regulatory partner Howard Sklamberg was quoted in a recent article from Bloomberg Law that discusses the consequences of a potential government shutdown on FDA activities. While it is unlikely that activities related to the agency’s pandemic response would stop during a government shutdown, Sklamberg notes that FDA policymaking functions and surveillance inspections would likely be impacted.
» Read the full article (subscription required).